RACHAEL AVERETTE: Open Payments
NPI 1871289926 · NORTHPORT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,407 in 116 payments from 18 companies in 2025. Trend: 2023 $1,201 · 2024 $2,966 · 2025 $2,407
Food & beverage: $2,307Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $449 |
| Amgen Inc. | 19 | $382 |
| UCB, Inc. | 16 | $292 |
| Janssen Biotech, Inc. | 9 | $235 |
| GlaxoSmithKline, LLC. | 8 | $203 |
| Mallinckrodt Hospital Products Inc. | 5 | $175 |
| Novartis Pharmaceuticals Corporation | 6 | $124 |
| AstraZeneca Pharmaceuticals LP | 6 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $84 |
| Genentech USA, Inc. | 4 | $79 |
Products named: RINVOQ, Bimzelx, TREMFYA, BENLYSTA, ACTHAR, SKYRIZI, OTEZLA, KRYSTEXXA.
Industry payments across AL — which companies pay providers there.
